Skip to main content
. 2017 Feb 1;61(5):438–446. doi: 10.1590/2359-3997000000254

Table 4. Cytokines levels according to genotypes in T2DM patients group.

Polymorphism Cytokine (fg/mL) p p’
TNF-α (-308 G/A) (rs1800629) GG (n = 78) 95 (45) 0.137 -
GA (n = 23) 85 (44)
AA (n = 1) 47.5
IL-6 (-174 C/G) (rs1800795) CC1 (n = 7) 1901 (3167) 0.026* pa = 0.047
CG2 (n = 26) 496 (746) pb = 0.210
GG3 (n = 69) 878 (945) pc = 0.023
IL-10 (-1082 G/A) (rs1800896) GG (n = 12) 202 (62) 0.181 -
GA (n = 47) 178 (68)
AA (n = 43) 199 (87)
IL-10 (-819 T/C) (rs1800871) TT1 (n = 13) 256 (207) 0.021* pa = 0.066
TC2 (n = 40) 184 (90) pb = 0.006*
CC3 (n = 49) 182 (57) pc = 0.207
IL-10 (-592 A/C) (rs1800872) AA (n = 14) 249 (212) 0.055 -
AC (n = 39) 185 (91)
CC (n = 49) 182 (57)

TNF-α: tumor necrosis factor-alpha; IL-6: interleukin-6; IL-10: interleukin-10.

Cytokine levels: no normal variable; the data are shown as “median (IQR)”.

* p < 0.05 was considered statistically significant.

* p’ < 0.02 was considered statistically significant (Mann-Whitney test with Bonferroni’s Correction).

pa: genotype 1 versus genotype 2.

pb: genotype 1 versus genotype 3.

pc: genotype 2 versus genotype 3.

data only one individual.